Velandai Srikanth

Velandai Srikanth

Auto-generated profile, based on publicly available information

Velandai Srikanth

Department of Medicine, Peninsula Clinical School, Central Clinical School, Monash University, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
VSVelandai K. Srikanth
Velandai K. Srikanth
JFJayne L. Fryer
Jayne L. Fryer
GZGuangju Zhai
Guangju Zhai
TWTania M. Winzenberg
Tania M. Winzenberg
DHDavid Hosmer
David Hosmer
GJGraeme Jones
Graeme Jones

1 November 2017 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
JEJulian H. Elliott
Julian H. Elliott
ASAnneliese Synnot
Anneliese Synnot
TTTari Turner
Tari Turner
MSMark Simmonds
Mark Simmonds
EAElie Akl
Elie Akl
LPLeslea Pearson
Leslea Pearson

13 November 2013 in Diabetes Care
Verified
Journal Article
Open access
PDF file
CMChris Moran
Chris Moran
TPThanh G. Phan
Thanh G. Phan
JCJian Chen
Jian Chen
LBLeigh Blizzard
Leigh Blizzard
RBRichard Beare
Richard Beare
VSVelandai Srikanth
Velandai Srikanth
OBJECTIVE Type 2 diabetes (T2DM) is associated with brain atrophy and cerebrovascular disease. We aimed to define the regional distribution of brain atrophy in T2DM and to examine whether atrophy or cerebrovascular lesions are feasible links between T2DM and cognitive function. RESEARCH DESIGN AND METHODS This cross-sectional study used magnetic resonance imaging (MRI) scans and cognitive tests in 350 participants with T2DM and 363 participants without T2DM. With voxel-based morphometry, we studied the regional distribution of atrophy in T2DM. We measured cerebrovascular lesions (infarcts, microbleeds, and white matter hyperintensity [WMH] volume) and atrophy (gray matter, white matter, and hippocampal volumes) while blinded to T2DM status. With use of multivariable regression, we examined for mediation or effect modification of the association between T2DM and cognitive measures by MRI measures. RESULTS T2DM was associated with more cerebral infarcts and lower total gray, white, and hippocampal volumes (all P < 0.05) but not with microbleeds or WMH. T2DM-related gray matter loss was distributed mainly in medial temporal, anterior cingulate, and medial frontal lobes, and white matter loss was distributed in frontal and temporal regions. T2DM was associated with poorer visuospatial construction, planning, visual memory, and speed (P ≤ 0.05) independent of age, sex, education, and vascular risk factors. The strength of these associations was attenuated by almost one-half when adjusted for hippocampal and total gray volumes but was unchanged by adjustment for cerebrovascular lesions or white matter volume. CONCLUSIONS Cortical atrophy in T2DM resembles patterns seen in preclinical Alzheimer disease. Neurodegeneration rather than cerebrovascular lesions may play a key role in T2DM-related cognitive impairment.

1 June 2020 in The Lancet Diabetes & Endocrinology
Verified
Journal Article
Closed access
VSVelandai Srikanth
Velandai Srikanth
ASAlan J Sinclair
Alan J Sinclair
FHFelicia Hill-Briggs
Felicia Hill-Briggs
CMChris Moran
Chris Moran
GBGeert Jan Biessels
Geert Jan Biessels

19 August 2014 in Neurology
Verified
Journal Article
Closed access
PDF file
JVJoe Verghese
Joe Verghese
Cedric AnnweilerCedric Annweiler
Cedric Annweiler
EAEmmeline Ayers
Emmeline Ayers
NBNir Barzilai
Nir Barzilai
OBOlivier Beauchet
Olivier Beauchet
CWCuiling Wang
Cuiling Wang
Objectives: Our objective is to report prevalence of motoric cognitive risk syndrome (MCR), a newly described predementia syndrome characterized by slow gait and cognitive complaints, in multiple countries, and its association with dementia risk. Methods: Pooled MCR prevalence analysis of individual data from 26,802 adults without dementia and disability aged 60 years and older from 22 cohorts from 17 countries. We also examined risk of incident cognitive impairment (Mini-Mental State Examination decline ≥4 points) and dementia associated with MCR in 4,812 individuals without dementia with baseline Mini-Mental State Examination scores ≥25 from 4 prospective cohort studies using Cox models adjusted for potential confounders. Results: At baseline, 2,808 of the 26,802 participants met MCR criteria. Pooled MCR prevalence was 9.7% (95% confidence interval [CI] 8.2%–11.2%). MCR prevalence was higher with older age but there were no sex differences. MCR predicted risk of developing incident cognitive impairment in the pooled sample (adjusted hazard ratio [aHR] 2.0, 95% CI 1.7–2.4); aHRs were 1.5 to 2.7 in the individual cohorts. MCR also predicted dementia in the pooled sample (aHR 1.9, 95% CI 1.5–2.3). The results persisted even after excluding participants with possible cognitive impairment, accounting for early dementia, and diagnostic overlap with other predementia syndromes. Conclusion: MCR is common in older adults, and is a strong and early risk factor for cognitive decline. This clinical approach can be easily applied to identify high-risk seniors in a wide variety of settings.

1 May 2011 in Neurobiology of Aging
Verified
Journal Article
Closed access
VSVelandai Srikanth
Velandai Srikanth
AMAnnette Maczurek
Annette Maczurek
TPThanh Phan
Thanh Phan
MSMegan Steele
Megan Steele
BWBernadette Westcott
Bernadette Westcott
GMGerald Münch
Gerald Münch